PGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Insulin resistance is a major hallmark in the development of type 2 diabetes, which is characterized by an impaired ability of insulin to inhibit glucose output from the liver and to promote glucose uptake in muscle. The nuclear hormone receptor coactivator PGC-1 (peroxisome proliferator-activated (PPAR)-gamma coactivator-1) has been implicated in the onset of type 2 diabetes. Hepatic PGC-1 expression is elevated in mouse models of this disease, where it promotes constitutive activation of gluconeogenesis and fatty acid oxidation through its association with the nuclear hormone receptors HNF-4 and PPAR-alpha, respectively. Here we show that PGC-1-deficient mice, generated by adenoviral delivery of PGC-1 RNA interference (RNAi) to the liver, experience fasting hypoglycemia. Hepatic insulin sensitivity was enhanced in PGC-1-deficient mice, reflecting in part the reduced expression of the mammalian tribbles homolog TRB-3, a fasting-inducible inhibitor of the serine-threonine kinase Akt/PKB (ref. 6). We show here that, in the liver, TRB-3 is a target for PPAR-alpha. Knockdown of hepatic TRB-3 expression improved glucose tolerance, whereas hepatic overexpression of TRB-3 reversed the insulin-sensitive phenotype of PGC-1-deficient mice. These results indicate a link between nuclear hormone receptor and insulin signaling pathways, and suggest a potential role for TRB-3 inhibitors in the treatment of type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PGC-1α is elevated in liver in mouse models of diabetes and regulates the expression of TRB3, an inhibitor of insulin-dependent AKT activation [87, 88].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [88]
Citations
Cites
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326 · cited 1×
“jpg" NDATA ITEM> ]> Insulin resistance is a major hallmark in the development of type 2 diabetes, which is characterized by an impaired ability of insulin to inhibit glucose output from the liver and to promote glucose uptake in muscl”
BackgroundWu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80611-x · Cited by 4,139 · cited 1×
“Despite its importance in promoting mitochondrial function in skeletal muscl”
BackgroundCho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,836
Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821
Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting
Kersten, S., Seydoux, J., Peters, J. M., Gonzalez, F. J., Desvergne, B., & Wahli, W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6223 · Cited by 1,649 · cited 1×
“The hypoglycemic fatty liver phenotype in PGC-1 knockdown mice is reminiscent of the phenotype of PPAR-α-deficient mice, which have hepatic steatosis and hypoglycemi”
BackgroundCREB regulates hepatic gluconeogenesis through the coactivator PGC-1
Herzig, S., Long, F., Jhala, U. S., Hedrick, S., Quinn, R., Bauer, A., Rudolph, D., Schutz, G., Yoon, C., Puigserver, P., et al. (2001) · Nature · doi:10.1038/35093131 · Cited by 1,440
Self-citationKliewer, S. A., Forman, B. M., Blumberg, B., Ong, E. S., Borgmeyer, U., Mangelsdorf, D. J., Umesono, K., & Evans, R. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7355 · Cited by 1,400 · cited 1×
“Overexpression of PPAR-α and its heterodimeric partner RX”
BackgroundSelf-citationDresner, A., Laurent, D., Marcucci, M., Griffin, M. E., Dufour, S., Cline, G. W., Slezak, L. A., Andersen, D. K., Hundal, R. S., Rothman, D. L., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5001 · Cited by 1,311 · cited 1×
“Free fatty acids are thought to inhibit glucose us”
BackgroundMichael, M. D., Kulkarni, R. N., Postic, C., Previs, S. F., Shulman, G. I., Magnuson, M. A., & Kahn, C. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00015-8 · Cited by 1,296 · cited 1×
“Both TRB-3 mRNA and PGC-1 mRNA were elevated in LIRKO mice, which have a knockout of the insulin receptor in live”
BackgroundSelf-citationTen years of protein kinase B signalling: a hard Akt to follow
Brazil, D. P., & Hemmings, B. A. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01958-2 · Cited by 1,177 · cited 1×
“In the fed state, insulin inhibits hepatic glucose output through a cascade of phospholipid-dependent kinases that activate Akt/PKB by phosphorylating it at Thr308 and Ser473 (refs”
Background
Cited by
Items 201–300 of 552
Sonne, D. P., Hansen, M., & Knop, F. K. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0154 · Cited by 75
Ma, D., Li, S., Lucas, E. K., Cowell, R. M., & Lin, J. D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.151688 · Cited by 73
TRB3 Function in Cardiac Endoplasmic Reticulum Stress
Avery, J., Etzion, S., DeBosch, B. J., Jin, X., Lupu, T. S., Beitinjaneh, B., Grand, J., Kovács, A. D., Sambandam, N., & Muslin, A. J. (2010) · Circulation Research · doi:10.1161/circresaha.109.211920 · Cited by 76
Identification of the tyrosine phosphatase PTP-MEG2 as an antagonist of hepatic insulin signaling
Cho, C. Y., Koo, S., Wang, Y., Callaway, S., Hedrick, S. A., Mak, P. A., Orth, A. P., Peters, E. C., Sáez, E., Montminy, M., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.03.006 · Cited by 77
“Rat primary hepatocytes were prepared from 200–300 g Sprague-Dawley rats by collagenase perfusion method as described previously (Koo et al., 2004).”
InfluentialSelf-citationMitostasis, Calcium and Free Radicals in Health, Aging and Neurodegeneration
Godoy, J. A., Ríos, J. A., Picón-Pagès, P., Herrera-Fernández, V., Swaby, B., Crepin, G., Vicente, R., Fernández‐Fernández, J. M., & Muñoz, F. J. (2021) · Biomolecules · doi:10.3390/biom11071012 · Cited by 76
“Regarding mitochondria, SIRT1 overexpression protects against A β damages at the level of synaptic contacts, dendritic branching and mitochondrial morphology [273].”
BackgroundHebbachi, A. M., Knight, B. L., Wiggins, D., Patel, D. D., & Gibbons, G. F. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709471200 · Cited by 68
Dual role of the coactivator TORC2 in modulating hepatic glucose output and insulin signaling
Canettieri, G., Koo, S., Berdeaux, R., Heredia, J., Hedrick, S. A., Zhang, X., & Montminy, M. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.008 · Cited by 74
“Culture of primary hepatocytes Rat primary hepatocytes were prepared from 200–300 g of Sprague-Dawley rats by collagenase perfusion method as described previously (Koo et al., 2004).”
MethodSelf-citationSung, H. Y., Francis, S., Crossman, D. C., & Kiss‐Toth, E. (2005) · Immunology Letters · doi:10.1016/j.imlet.2005.11.010 · Cited by 82
Nuclear receptor coregulators as a new paradigm for therapeutic targeting
Hsia, E. Y., Goodson, M. L., Zou, J. X., Privalsky, M. L., & Chen, H.-W. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.09.016 · Cited by 67
“Liver-specific expression of PGC-1α transgene increased blood glucose and insulin levels in normal non-fasting animals [62], while PGC-1 deficiency in the liver enhanced insulin sensitivity [68].”
BackgroundYao, X.-H., & Nyomba, B. L. G. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00804.2007 · Cited by 69
Tripathy, S., Torres‐Gonzalez, M., & Jump, D. Β. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m006080 · Cited by 75
Lee, S. M., Zhang, Y., Tsuchiya, H., Smalling, R., Jetten, A. M., & Wang, L. (2015) · Hepatology · doi:10.1002/hep.27437 · Cited by 68
Functional effects of muscle PGC-1alpha in aged animals
Yang, S., Loro, E., Wada, S., Kim, B., Tseng, W.-J., Li, K., Khurana, T. S., & Arany, Z. (2020) · Skeletal Muscle · doi:10.1186/s13395-020-00231-8 · Cited by 68
“In addition, PGC-1alpha promotes brown fat differentiation and thermogenesis [4], hepatic gluconeogenesis [5], cardiac homeostasis [6], and axonal integrity in the brain [7].”
BackgroundUpregulation of miR-15b in NAFLD models and in the serum of patients with fatty liver disease
Zhang, Y., Cheng, X., Lu, Z., Wang, J., Chen, H., Fan, W., Gao, X., & Li, J. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.11.025 · Cited by 69
PCAF Improves Glucose Homeostasis by Suppressing the Gluconeogenic Activity of PGC-1α
Sun, C., Wang, M., Liu, X., Luo, L., Li, K., Zhang, S., Wang, Y., Yang, Y., Ding, F., & Gu, X. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.11.029 · Cited by 67
Prevention and Reversal of Obesity and Glucose Intolerance in Mice by DHA Derivatives
Rossmeisl, M., Jelenik, T., Jilkova, Z., Slamova, K., Kus, V., Hensler, M., Medrikova, D., Povysil, C., Flachs, P., Mohamed‐Ali, V., et al. (2009) · Obesity · doi:10.1038/oby.2008.602 · Cited by 66
“However, the coordinated regulation of these metabolic pathways by physiological stimuli such as fasting (35) might be dramatically different from the situation, when hepatic fatty acid oxidation is stimulated by pharmacological activation of PPAR-α.”
BackgroundResultNovel liver-specific TORC2 siRNA corrects hyperglycemia in rodent models of type 2 diabetes
Saberi, M., Bjelica, D., Schenk, S., Imamura, T., Bandyopadhyay, G. K., Li, P., Jadhar, V., Vargeese, C., Wang, W., Bowman, K., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00158.2009 · Cited by 69
Self-citationEffect of TRB3 on Insulin and Nutrient-stimulated Hepatic p70 S6 Kinase Activity
Matsushima, R., Harada, N., Webster, N. J. G., Tsutsumi, Y. M., & Nakaya, Y. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511636200 · Cited by 77
Salt-inducible Kinase Regulates Hepatic Lipogenesis by Controlling SREBP-1c Phosphorylation
Yoon, Y.-S., Seo, W.-Y., Lee, M.-W., Kim, S.-T., & Koo, S.-H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900096200 · Cited by 64
Self-citationMartin-Murphy, B. V., You, Q., Wang, H., De La Houssaye, B. A., Reilly, T. P., Friedman, J. E., & Ju, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0080949 · Cited by 62
Lee, M. Y., Choi, R., Kim, H. M., Cho, E. J., Kim, B. H., Choi, Y. S., Naowaboot, J., Lee, E. Y., Yang, Y. C., Shin, J. Y., et al. (2012) · Experimental & Molecular Medicine · doi:10.3858/emm.2012.44.10.066 · Cited by 64
“However, PGC-1α expression is reported to be elevated in type 2 diabetic mice, and elevated hepatic PGC-1α expression was reported to increase PEPCK and contribute to fatty liver (Koo et al., 2004).”
BackgroundDecreased Gluconeogenesis in the Absence of Cystathionine Gamma-Lyase and the Underlying Mechanisms
Untereiner, A. A., Wang, R., Ju, Y., & Wu, L. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6369 · Cited by 65
Uebanso, T., Taketani, Y., Fukaya, M., Sato, K., Takei, Y., Sato, T., Sawada, N., Amo, K., Harada, N., Arai, H., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00014.2009 · Cited by 69
Prakash, P., Singh, V., Jain, M. K., Rana, M., Khanna, V., Barthwal, M. K., & Dikshit, M. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.01.038 · Cited by 65
Wang, M., Luo, L., Yao, L., Wang, C., Jiang, K., Liu, X., Xu, M., Shen, N., Guo, S., Sun, C., et al. (2016) · Scientific Reports · doi:10.1038/srep25399 · Cited by 65
Wan, J., Wu, X., Chen, H., Xia, X., Song, X., Chen, S., Lu, X., Jin, J., Su, Q., Cai, D., et al. (2020) · Aging Cell · doi:10.1111/acel.13238 · Cited by 65
“Besides, TRB3 was shown to inhibit insulin signaling and promote insulin resistance in the liver (Du, Herzig, Kulkarni, & Montminy, 2003; Koo et al., 2004; Yu et al., 2015).”
BackgroundGrabacka, M., Pierzchalska, M., & Reiss, K. (2013) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201011314030009 · Cited by 58
Lactobacillus acidophilus NS1 attenuates diet-induced obesity and fatty liver
Park, S. S., Lee, Y., Song, S., Kim, B., Kang, H., Oh, S., & Kim, E. (2018) · Journal of Endocrinology · doi:10.1530/joe-17-0592 · Cited by 62
Therapeutic Mechanisms of Herbal Medicines Against Insulin Resistance: A Review
Li, J., Bai, L., Wei, F., Zhao, J., Wang, D., Xiao, Y., Yan, W., & Wei, J. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00661 · Cited by 64
“…and insulin action, and the results indicate that its therapeutic effect is related to the upregulation of PPARγ expression in liver tissue (Nan Xia et al., 2013) and PPARγ coactivator 1α (PGC1α), which is a PPAR-mediated transcriptional coactivator of fatty acid oxidation (Koo et al., 2004).”
BackgroundMAZZIO, E. A., Boukli, N. M., Rivera, N., & Soliman, K. F. A. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02206.x · Cited by 68
Yoshizumi, S., Suzuki, S., Hirai, M., Hinokio, Y., Yamada, T., Yamada, T., Tsunoda, U., Aburatani, H., Yamaguchi, K., Miyagi, T., et al. (2007) · Metabolism · doi:10.1016/j.metabol.2006.10.027 · Cited by 66
IYNEDJIAN, P. B. (2005) · Biochemical Journal · doi:10.1042/bj20041425 · Cited by 61
Pyruvate induces mitochondrial biogenesis by a PGC-1 α-independent mechanism
Wilson, L., Yang, Q., Szustakowski, J. D., Gullicksen, P. S., & Halse, R. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00428.2006 · Cited by 67
“A recombinant adenoviral vector expressing a shRNA targeted to mouse PGC-1α was kindly provided by Dr. Marc Montminy, Salk Institute for Biological Studies and was generated as described by Koo et al (9).”
MethodCastillero, E., Nieto-Bona, M. P., Fernández-Galaz, C., Martín, A. I., López-Menduiña, M., Granado, M., Villanúa, M. A., & López-Calderón, A. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00590.2010 · Cited by 58
Patel, T. P., Rawal, K., Soni, S., & Gupta, S. S. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.07.028 · Cited by 60
Aberrant hepatic TRIB3 gene expression in insulin-resistant obese humans
Oberkofler, H., Pfeifenberger, A., Soyal, S. M., Felder, T. K., Hahne, P., Miller, K., Krempler, F., & Patsch, W. (2010) · Diabetologia · doi:10.1007/s00125-010-1772-2 · Cited by 59
“Furthermore hepatic Trib3 gene knock-down enhanced insulin sensitivity, whereas adenovirus-mediated hepatic overexpression of Trib3 promoted hyperglycaemia and glucose intolerance in wild-type mice [ 5 ].”
BackgroundInfluentialQiao, L., MacLean, P. S., You, H., Schaack, J. B., & Shao, J. (2006) · Endocrinology · doi:10.1210/en.2005-1507 · Cited by 57
Toxicogenomic evaluation of microcystin-LR treated with ultrasonic irradiation
Hudder, A., Song, W., Ο'Shea, K. Ε., & Walsh, P. J. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.02.004 · Cited by 57
“In fact it has been suggested that increased expression of the Tribbles gene plays a key role in insulin resistance in the diabetic liver and that it may be a suitable therapeutic target for treatment of Type II Diabetes (Koo et al., 2004).”
BackgroundYao, X., Chen, L., & Nyomba, B. L. G. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01115.2005 · Cited by 61
“experience fasting hypoglycemia ( 25 ), whereas hepatic PGC-1α expression is elevated in”
BackgroundRagozin, S., Niemeier, A., Laatsch, A., Loeffler, B., Merkel, M., Beisiegel, U., & Heeren, J. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000166616.86723.d0 · Cited by 56
Westerbacka, J., Cornér, A., Kannisto, K., Kolak, M., Makkonen, J., Korsheninnikova, E., Nyman, T., Hamsten, A., Fisher, R. M., & Yki‐Järvinen, H. (2005) · Diabetologia · doi:10.1007/s00125-005-0075-5 · Cited by 61
“Deletion or overexpression of each of these genes has been shown to modulate insulin action in mouse models [21, 49– 52].”
BackgroundPost-transcriptional activation of PPAR alpha by KLF6 in hepatic steatosis
Bechmann, L. P., Vetter, D., Ishida, J., Hannivoort, R. A., Lang, U. E., Kocabayoglu, P., Fiel, M. I., Muñoz, Ú., Patman, G., Ge, F., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.01.020 · Cited by 56
“PPARa activation transactivates Trb3, which is further augmented by PGC1a co-activation [15,31].”
BackgroundTRB3 interacts with CtIP and is overexpressed in certain cancers
Xu, J., Lv, S., Yan, Q., Shu, F., Xu, Y., Chen, J., Xu, B.-E., Sun, X., & Wu, J. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.09.025 · Cited by 55
Cyclin-Dependent Kinase-9: An RNAPII Kinase at the Nexus of Cardiac Growth and Death Cascades
Sano, M., & Schneider, M. D. (2004) · Circulation Research · doi:10.1161/01.res.0000146675.88354.04 · Cited by 54
Hepatic ATGL knockdown uncouples glucose intolerance from liver TAG accumulation
Ong, K. T., Mashek, M. T., Bu, S. Y., & Mashek, D. G. (2012) · The FASEB Journal · doi:10.1096/fj.12-213454 · Cited by 55
Andreozzi, F., Formoso, G., Prudente, S., Hribal, M. L., Pandolfi, A., Bellacchio, E., Silvestre, S. D., Trischitta, V., Consoli, A., & Sesti, G. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.162883 · Cited by 58
Satoh, T., Satoh, K., Yaoita, N., Kikuchi, N., Omura, J., Kurosawa, R., Numano, K., Al-Mamun, M. E., Siddique, M. A. H., Sunamura, S., et al. (2017) · Circulation Research · doi:10.1161/circresaha.117.310640 · Cited by 53
McMeekin, L. J., Fox, S. N., Boas, S. M., & Cowell, R. M. (2021) · Cells · doi:10.3390/cells10020352 · Cited by 58
TRIB3 is implicated in glucotoxicity- and oestrogen receptor-stress-induced β-cell apoptosis
Qian, B., Wang, H., Men, X., Zhang, W., Cai, H., Xu, S., Xu, Y., Ye, L., Wollheim, C. B., & Lou, J. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0331 · Cited by 51
Goto, T., Kim, Y.-I., Funakoshi, K., Teraminami, A., Uemura, T., Hirai, S., Lee, J.-Y., Makishima, M., Nakata, R., Inoue, H., et al. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00061.2011 · Cited by 57
Kiss‐Toth, E., Wyllie, D. H., Holland, K., Marsden, L., Jozsa, V., Oxley, K. M., Polgár, T., Qwarnström, E. E., & Dower, S. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.04.012 · Cited by 52
“Recent reports demonstrate that tribbles 3 is able to interact with and modulate the activity of p65 [37] ATF4 [38] and Akt [39,40].”
BackgroundRebollo, A., Roglans, N., Baena, M., Sánchez, R. M., Merlos, M., Alegret, M., & Laguna, J. C. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.01.002 · Cited by 53
Zhu, L., Wang, A., Luo, P., Wang, X., Jiang, D.-S., Deng, W., Zhang, X., Wang, T., Liu, Y., Gao, L., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.01.011 · Cited by 51
Liver and insulin resistance: New wine in old bottle!!!
Patel, B. M., & Goyal, R. K. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172657 · Cited by 54
Bellafante, E., Murzilli, S., Salvatore, L., Latorre, D., Villani, G., & Moschetta, A. (2013) · Hepatology · doi:10.1002/hep.26222 · Cited by 52
TRB3 modulates C2C12 differentiation by interfering with Akt activation
Kato, S., & Du, K. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.12.161 · Cited by 51
Peeters, A., Fraisl, P., van den Berg, S. A. A., van Themaat, E. V. L., van Kampen, A. H. C., Rider, M. H., Takemori, H., van Dijk, K. W., Veldhoven, P. P. V., Carmeliet, P., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.299727 · Cited by 61
Insulin Regulation of Hepatic Lipid Homeostasis
Uehara, K., Santoleri, D., Whitlock, A. E. G., & Titchenell, P. M. (2023) · Comprehensive Physiology · doi:10.1002/cphy.c220015 · Cited by 49
“Montminy et al. elucidated the mechanism in which PPAR α and PGC-1 induces tribbles homolog , TRB-3, during fasting, which in turn is an inhibitor of AKT signaling (165).”
InfluentialLee, G., Hwang, J.-D., Choi, J., Park, H., Cho, J., Kim, K., Chae, H., & Kim, H. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.05.004 · Cited by 58
MiR-30b-5p regulates the lipid metabolism by targeting PPARGC1A in Huh-7 cell line
Zhang, Q. H., Ma, X., Dong, M., Tan, J., Zhang, J., Zhuang, L.-K., Liu, S., & Xin, Y. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01261-3 · Cited by 67
Chen, Y., Wang, J., Wang, Y., Wang, P., Zhou, Z., Wu, R., Xu, Q., You, H., Liu, Y., Wang, L., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27533-9 · Cited by 52
Cloning of the Rat Pyruvate Dehydrogenase Kinase 4 Gene Promoter
Ma, K., Zhang, Y., Elam, M. B., Cook, G. A., & Park, E. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502236200 · Cited by 52
Sex-different hepatic glycogen content and glucose output in rats
Gustavsson, C., Yassin, K., Wahlstrom, E. H., Cheung, L. K., Lindberg, J., Brismar, K., Östenson, C., Norstedt, G., & Tollet‐Egnell, P. (2010) · BMC Biochemistry · doi:10.1186/1471-2091-11-38 · Cited by 54
“PPARa is also an important mediator of gluconeogenesis [ 54-57 ].”
BackgroundWang, G. Y., Qin, S. L., Zheng, Y. N., Geng, H., Chen, L., Yao, J. H., & Deng, L. (2023) · Animal nutrition · doi:10.1016/j.aninu.2023.07.001 · Cited by 50
“Several rate-limiting enzymes are involved in regulating the process of hepatic gluconeogenesis, including fructose 1,6-bisphosphatase (FBP1/2), cytosolic and mitochondrial phosphoenolpyruvate carboxykinase (PCK1/2), and glucose 6-phosphatase (G6PC) (Aschenbach et al., 2010; Pilkis et al., 1988; Pilkis and Granner, 19…”
BackgroundInfluentialControl of Adipose Tissue Inflammation Through TRB1
Ostertag, A., Jones, A., Rose, A. J., Liebert, M., Kleinsorg, S., Reimann, A., Vegiopoulos, A., Díaz, M. B., Strzoda, D., Yamamoto, M., et al. (2010) · Diabetes · doi:10.2337/db09-1537 · Cited by 55
Self-citationJones, A., Kulozik, P., Ostertag, A., & Herzig, S. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-0973 · Cited by 48
“But this beneficial effect is contradicted by studies, showing that in the liver PGC1α inhibits the insulin signaling pathway [328] and suppresses β-cell metabolism and insulin secretion in mice [329].”
Self-citationZhou, H., Luo, Y., Chen, J., Hu, J. X., Luo, Y., Wang, W., Zeng, Y., & Xiao, L. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1453 · Cited by 47
Yacoub Wasef, S. Z., Robinson, K. A., Berkaw, M. N., & Buse, M. G. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00117.2006 · Cited by 47
Yu, J., Xiao, F., Guo, Y., Deng, J., Liu, B., Zhang, Q., Li, K., Wang, C., Chen, S., & Guo, F. (2014) · Diabetes · doi:10.2337/db14-1368 · Cited by 47
Chung, Y. W., Ahmad, F., Tang, Y., Hockman, S. C., Kee, H. J., Berger, K., Guirguis, E., Choi, Y. H., Schimel, D., Aponte, A. M., et al. (2017) · Scientific Reports · doi:10.1038/srep40445 · Cited by 50
Hasei, S., Yamamotoya, T., Nakatsu, Y., Ohata, Y., Itoga, S., Nonaka, Y., Matsunaga, Y., Sakoda, H., Fujishiro, M., Kushiyama, A., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084040 · Cited by 47
Therapies modulating insulin resistance in Parkinson’s disease: A cross talk
Sharma, T., Kaur, D., Grewal, A. K., & Singh, T. G. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135754 · Cited by 44
Kitazawa, M., Nagano, M., Masumoto, K., Shigeyoshi, Y., Natsume, T., & Hashimoto, S. (2011) · Endocrinology · doi:10.1210/en.2010-1407 · Cited by 49
Liu, J., Zhang, W., Chuang, G. C., Hill, H. S., Tian, L., Fu, Y., Moellering, D. R., & Garvey, W. T. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00663.2011 · Cited by 48
Satoh, H., Nguyen, M. T., Kudoh, A., & Watanabe, T. (2013) · Nutrition and Diabetes · doi:10.1038/nutd.2013.11 · Cited by 44
Self-citationPGC-1α, un co-activateur transcriptionnel impliqué dans le métabolisme
Tiraby, C., & Langin, D. (2005) · médecine/sciences · doi:10.1051/medsci/200521149 · Cited by 52
“En partenariat avec PPARα, PGC-1α induit l’expression de TRB-3, un inhibiteur de la protéine kinase B qui relaie l’action de l’insuline [37].”
BackgroundLelliott, C. J., Ljungberg, A., Ahnmark, A., William-Olsson, L., Ekroos, K., Elmgren, A., Arnerup, G., Shoulders, C. C., Oscarsson, J., & Lindén, D. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.155739 · Cited by 44
Selim, E., Frkanec, J. T., & Cunard, R. A. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.06.006 · Cited by 51
Circadian rhythm of lipid metabolism
Sinturel, F., Spaleniak, W., & Dibner, C. (2022) · Biochemical Society Transactions · doi:10.1042/bst20210508 · Cited by 46
Functional crosstalk of CAR–LXR and ROR–LXR in drug metabolism and lipid metabolism
Xiao, L., Xie, X., & Zhai, Y. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.07.006 · Cited by 47
Bile acids and insulin resistance: implications for treating nonalcoholic fatty liver disease
WEI, J., QIU, D. K., & MA, X. (2009) · Journal of Digestive Diseases · doi:10.1111/j.1751-2980.2009.00369.x · Cited by 43
Kim, J. H., Shin, H. D., Park, B. L., Cho, Y., Kim, S. Y., Lee, H. K., & Park, K. S. (2005) · Diabetologia · doi:10.1007/s00125-005-1793-4 · Cited by 48
“Furthermore, hepatic PGC-1α expression increases in a mouse model of diabetes, and PGC1α deficiency in diabetic mice, generated by adenoviral delivery of PGC-1α siRNA to the liver, improves glucose tolerance [6].”
BackgroundFinamor, I., Bressan, C. A., Torres-Cuevas, I., Rius‐Pérez, S., da Veiga, M. L., da Rocha, M. I. D. U. M., Pavanato, M. A., & Pérez, S. (2021) · Biology · doi:10.3390/biology10020082 · Cited by 45
Das, R., Sebo, Z. L., Pence, L., & Dobens, L. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109530 · Cited by 49
Tomčík, M., Palumbo‐Zerr, K., Zerr, P., Šumová, B., Avouac, J., Dees, C., Distler, A., Bečvář, R., Distler, O., Schett, G. A., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206234 · Cited by 45
Bergeron, R., Yao, J., Woods, J. W., Zycband, E., Liu, C., Li, Z., Adams, A., Berger, J. P., Zhang, B. B., Moller, D. E., et al. (2006) · Endocrinology · doi:10.1210/en.2005-1535 · Cited by 45
Nuclear Forkhead Box O1 Controls and Integrates Key Signaling Pathways in Hepatocytes
Naïmi, M., Gautier, N., Chaussade, C., Valverde, A. M., Accili, D., & Van Obberghen, E. (2007) · Endocrinology · doi:10.1210/en.2006-1411 · Cited by 41
The dysfunction of hepatic transcriptional factors in mice with Huntington's Disease
Chiang, M., Chern, Y., & Juo, C. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.05.006 · Cited by 46
Glial cell line-derived neurotrophic factor protects against high-fat diet-induced obesity
Mwangi, S. M., Nezami, B. G., Obukwelu, B., Anitha, M., Marri, S., Fu, P. P., Epperson, M., Le, N., Shanmugam, M., Sitaraman, S. V., et al. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00364.2013 · Cited by 42
Zhang, X., Lv, Q., Jia, S., Chen, Y., Sun, C., Li, X., & Chen, K. (2016) · Food & Function · doi:10.1039/c6fo00397d · Cited by 42
Caffeine alters circadian rhythms and expression of disease and metabolic markers
Sherman, H., Gutman, R., Chapnik, N., Meylan, J., le Coutre, J., & Froy, O. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.02.008 · Cited by 47
Farnesoid X Receptor: A New Player in Glucose Metabolism?
Cariou, B., Durán-Sandoval, D., Kuipers, F., & Staels, B. (2005) · Endocrinology · doi:10.1210/en.2004-1595 · Cited by 43
“0013-7227/05/$15.00/0 Endocrinology 146(3):981–983 Printed in U.S.A. Copyright © 2005 by The Endocrine Society doi: 10.1210/en.2004-1595 981 Downloaded from https://academic.oup.com/endo/article-abstract/146/3/981/2499867 by guest on 27 July 2018 SHP has been shown to inhibit the transactivation of the PEPCK promoter…”
BackgroundInfluentialBorsting, E., Patel, S. V., Declèves, A., Lee, S. J., Rahman, Q. M., Akira, S., Satriano, J. A., Sharma, K., Vallon, V., & Cunard, R. A. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013070811 · Cited by 42
Tikka, A., Soronen, J., Laurila, P.-P., Metso, J., Ehnholm, C., & Jauhiainen, M. (2014) · Bioscience Reports · doi:10.1042/bsr20140115 · Cited by 39
KLF10 transcription factor regulates hepatic glucose metabolism in mice
Yang, X., Chen, Q., Sun, L., Zhang, H., Yao, L., Cui, X., Gao, Y., Fang, F., & Chang, Y. (2017) · Diabetologia · doi:10.1007/s00125-017-4412-2 · Cited by 39
“The sequence of siRNA against Pgc-1α (siPgc-1α) was generated as previously described [22].”
MethodTribbles Pseudokinase 3 Regulation and Contribution to Cancer
Stefanovska, B., André, F., & Fromigué, O. (2021) · Cancers · doi:10.3390/cancers13081822 · Cited by 40
“The transcriptional coactivator PGC-1α (Peroxisome proliferator-activated receptor gamma coactivator-1 alpha) also promotes TRIB3 expression which leads to induced insulin resistance in liver cells [27].”
BackgroundStaudinger, J. L., & Lichti-Kaiser, K. (2007) · Molecular Pharmaceutics · doi:10.1021/mp700098c · Cited by 41
Misra, J., Kim, D.-K., Choi, W., Koo, S., Lee, C.-H., Back, S.-H., Kaufman, R. J., & Choi, H.-S. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt429 · Cited by 43
Self-citationControl of Hepatic Gluconeogenesis by the Promyelocytic Leukemia Zinc Finger Protein
Chen, S., Qian, J., Shi, X., Gao, T., Liang, T., & Liu, C. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1164 · Cited by 44
“The promyelocytic leukemia zinc finger (PLZF) protein, also known as Zbtb 16 or Zfp 145, was first identified in 1993 in a patient with acute promyelocytic leukemia, in whom a reciprocal chromosomal translocation t(11;17) (q23;q21) resulted in a fusion with the RARA gene encoding retinoic acid receptor (12).”
BackgroundZhu, M. J., Kang, Y., Xue, Y., Liang, X., García, M. P. G., Rodgers, D. B., Kagel, D. R., & Du, . (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.10.012 · Cited by 39
Metadata
- Authors
- Koo, S.-H., Satoh, H., Herzig, S., Lee, C.-H., Hedrick, S., Kulkarni, R., Evans, R. M., Olefsky, J., & Montminy, M.
- Affiliations
- Salk Institute for Biological Studies (US)
- University of California San Diego (US)
- Joslin Diabetes Center (US)
- Corresponding author
- Montminy, Marc
- ORCID
- Venue
- Nature Medicine
- Published
- 2004-04-25
- Volume
- 10
- Issue
- 5
- Pages
- 530-534
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1603786143
- Cited by
- 550
- References
- 28
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 10 · 2023: 9 · 2022: 15 · 2021: 19 · 2020: 19 · 2019: 13 · 2018: 22 · 2017: 20 · 2016: 21 · 2015: 22 · 2014: 34 · 2013: 31 · 2012: 31
- FWCI
- 16.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM037828, GM R01 37828)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- PGC-1, insulin resistance, PPARα, type 2 diabetes, hepatic insulin sensitivity, glucose tolerance, Akt signaling, fasting hypoglycemia, nuclear receptors, hepatic gluconeogenesis, RNAi knockdown
- MeSH terms
- Animals, Base Sequence, Diabetes Mellitus, Type 2, DNA, Humans, Insulin Resistance, Liver, Male, Mice, Inbred C57BL, Mice, Obese, Transcription Factors, Signal Transduction, Rats, Wistar, Receptors, Cytoplasmic and Nuclear, Mice, Knockout, Cell Cycle Proteins, RNA Interference, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.